Medical, Surgical, and Interventional Management of Hypertrophic Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Internal Medicine

Background:

• Hypertrophic cardiomyopathy (HCM) is a prevalent yet often overlooked cardiac disorder.
• It presents with a varied phenotype, including left ventricular hypertrophy, outflow obstruction, diastolic dysfunction, and arrhythmias.
• HCM is frequently hereditary, linked to mutations in sarcomeric genes.

Purpose of the Study:

• To provide a practical overview of key aspects of hypertrophic cardiomyopathy.
• To discuss diagnostic evaluations, imaging techniques, and methods for provoking left ventricular outflow obstruction.
• To review current and emerging treatment strategies, including medical, interventional, and surgical options.

Main Methods:

• Review of current literature and clinical guidelines on hypertrophic cardiomyopathy.
• Discussion of diagnostic approaches, including imaging and genetic testing.
• Analysis of therapeutic interventions, encompassing medical management (negative inotropic therapy, myosin inhibition) and procedural options (septal reduction, mitral valve intervention).

Main Results:

• Integrated care involving medical, interventional, and surgical approaches can significantly impact disease burden, quality of life, and mortality in HCM patients.
• Effective management strategies exist for both obstructive and nonobstructive forms of HCM.
• Various interventions, including septal reduction and mitral valve procedures, offer therapeutic options.

Conclusions:

• Hypertrophic cardiomyopathy requires a comprehensive management strategy tailored to individual patient phenotypes.
• While not curable, timely and appropriate interventions can substantially improve patient outcomes.
• Ongoing research and therapeutic advancements continue to refine the care of individuals with HCM.